News

A federal appeals court in San Francisco has heard arguments on whether the Trump administration should return control of ...
Merck’s MRK second-largest product is Gardasil, which is a vaccine for the prevention of certain cancers caused by human ...
For the 2025-2026 respiratory viral season, Moderna intends to have mResvia available for both FDA-approved patient populations.
A federal appeals court in San Francisco is set to hear arguments on whether the Trump administration should return control ...
Potential First-in-Class Respiratory Combination Vaccine Candidates SCB-1022 (RSV + hMPV) and SCB-1033 (RSV + hMPV + PIV3) Enter the Clinical Trial Stage -- ...
A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used ...
A Centers for Disease Control and Prevention official who led the agency's network to study hospitalization trends from infectious diseases like COVID-19 has resigned in protest following Health and ...